< Back to latest news & events

News

New Practice at the EPO: Divisional Applications and Sequence Listings

November 2023

Safeguard measure: Excess page fees on ST.25 sequence listings included as part of a divisional application to be waived by the EPO.

Following the implementation of WIPO Sequence standard ST.26, the EPO has required that new divisional applications filed on or after 1 July 2022 require a sequence listing in the ST.26 format, even when the parent application contained an ST.25 standard compliant sequence listing. This practice has been met with concern from practitioners regarding the risk of added subject matter.

To address the concerns around the risk of adding or losing subject matter, the EPO has announced a new safeguard measure. The safeguard measure permits applicants to file the parent application’s ST.25 sequence listing in PDF format as part of the divisional application. Importantly, the ST.25 pages included as a safeguard are excluded from the page fee calculation. Alternatively, the divisional application may be filed by reference to the parent application. In doing so, applicants have the guarantee that the ST.25 sequence listing, which is part of the application, does not contain any additional subject-matter.  In any event, an ST.26 compliant sequence listing will still also need to be filed.

Page fees already paid for pages of sequence listings not complying with WIPO Standard ST.26 will not be refunded.

Full details are expected to be published in the November issue of the Official Journal.

Latest updates

Happy World IP Day!

This year’s theme is ‘IP and the SDGs: Building our common future with innovation and creativity’. At HGF we are committed to supporting our clients in sustainable technologies and routinely …

Read article

IP Ingredients, Part 12: Exploring colours in the food & drink sector – overcoming hurdles and leveraging colour trade marks

We will all recognise as consumers an instance of when we used the colour of a product or its packaging to identify a specific brand that we wanted to buy …

Read article

Medical 3D Technologies: From Scanning to Printing

When we think of 3D technologies, we often think of 3D printing, which, as discussed later, has seen rapid advances in recent years. However, a sometimes overlooked area of medical …

Read article

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

Intellectual Property (IP) is a core part of any business and particularly is a vital part of the strategic toolkit for any business that creates value through innovation and constant …

Read article

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article